Alternatives to Vitalex Health

The monthly plan is not monthly. Read live on 26 August 2026, PrescribedRx now sells both GLP-1s month to month — semaglutide at $189 and tirzepatide at $276 — which is a real improvement on the prepay-only structure it had in August. Then read its Purchase Terms: "Month to Month subscriptions automatically renew every 20 days. 3 Month subscriptions automatically renew every 10 weeks." A twenty-day cycle means about eighteen charges a year rather than twelve, so $189 a month is nearer $3,450 a year than $2,268 — roughly half again what the label implies. The prepaid tiers are still the best value and still carry the one genuinely honest number in this screen: $420 buys two paid months plus a free third, which is $140 across the three months it covers, and the site advertises the higher figure, $210, because it divides by the two paid months. Against that, the plan pages promise a "Money-back guarantee" while the Purchase Terms say an order is final and non-refundable once a consultation is completed and a prescription issued, with an administrative fee of up to $99 even for canceling beforehand. And PrescribedRx says of itself that it "is a patient management and marketing platform," does not employ physicians, does not dispense medication and does not compound anything.

Novi's month-to-month rates are $149 semaglutide and $179 tirzepatide, flat at every dose — but almost every number the site advertises is a prepay term price divided by its term. The '$88/mo' headline on Novi's own product page is the twelve-month row, and its homepage quotes '$133/mo' under a countdown, a figure that is not a monthly price on either product page. Its intake then serves a higher variant again. Its Terms require a three-month non-refundable commitment while its help center says there are no commitments at all, so the two things you most need to know — what leaves the account, and when you can stop — are the two things Novi contradicts itself on.

An MD-led, budget-friendly compounded shop that names its pharmacy partners — around $165/mo semaglutide or $200/mo tirzepatide standard — though pricing is packaged in 12-week blocks and the advertised rate is a new-patient discount off a higher renewal price.

An all-inclusive $89/mo semaglutide program, LegitScript-certified and licensed in all 50 states — undercut by a homepage that advertises a different $99 first-month figure for the same product, and a tirzepatide option that's listed but never separately priced.

A broader wellness platform with GLP-1s starting from $179/mo semaglutide and $255/mo tirzepatide, alongside a longevity catalog — though the 'From' pricing means the real ongoing cost isn't fully confirmed on the public pages.

A multi-category telehealth shop with some of the lowest disclosed GLP-1 starting prices in this batch — from $99/mo semaglutide, $140/mo tirzepatide — though the site's own disclosure that pricing 'may vary' means the real ongoing cost isn't fully locked in.

LegitScript-certified compounded semaglutide and tirzepatide, held flat at every dose — read live on 2026-08-26 the product pages still show "Starting at $199 $99 /month" and "$299 $183 /month", the higher figure struck through, exactly as they did three weeks earlier and still with no expiry on either discount. That is why this record ranks on $199 and $299: a discount with no stated end is a number you cannot plan against. The price genuinely includes the consultation, free cold-pack overnight shipping and every injection supply, and the flat-across-doses promise is stated in the first line of both pages. RxION is also more forthcoming than most about its own limits — it excludes New Jersey, Alaska and Mississippi in a footnote under the price, says that some states require a brief video consultation before a prescription can be issued, and states outright that it is not a pharmacy and that buying a program does not guarantee approval. What it does not publish is a physical address, the name of the pharmacy that fills your prescription, or how long any of it takes.

A genuinely async start in 45 states, wrapped around a price page that advertises one molecule and hides the other: tirzepatide runs $329 a month, 84% over the headline, and you cannot find that out without starting the intake.

One of the lowest disclosed GLP-1 starting prices in this round — from $99/mo semaglutide, $133/mo tirzepatide — with an explicit no-membership, no-hidden-fee claim, though the real ongoing rate at a working dose isn't confirmed.